NIH AIDS account is awarded to Ogilvy

WASHINGTON: Already well-known for 13 years of AIDS-related

campaigns, Ogilvy Public Relations Worldwide has beaten out more than a

dozen agencies to win a three-year contract to develop and implement a

national communications campaign to rally support for HIV vaccine

research. The first year of the contract is valued at dollars 3.4


On behalf of the National Institute of Allergy and Infectious Diseases

(NIAID) division of the National Institutes of Health (NIH), Ogilvy will

create a national communications campaign to drum up awareness for HIV

vaccine research.

Ogilvy's program will include strategies to keep the public up to date

with NIAID's progress on an HIV/AIDS vaccine and to inform individuals

and community and health leaders of the need for public involvement in

vaccine development and testing.

Tom Beall, co-director of Ogilvy PR's global health & medical practice,

has assigned a core team of six people to the account.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in